We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

162 hedge funds and large institutions have $296M invested in Niagen Bioscience in 2025 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 68 increasing their positions, 38 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more call options, than puts

Call options by funds: $1.9M | Put options by funds: $1.03M

79% more repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 38

33% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 24

5% more funds holding

Funds holding: 155 → 162 (+7)

2.97% more ownership

Funds ownership: 36.84% → 39.8% (+3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

29% less capital invested

Capital invested by funds: $418M → $296M (-$122M)

Holders
162
Holders Change
+7
Holders Change %
+4.52%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
32
Increased
68
Reduced
38
Closed
24
Calls
$1.9M
Puts
$1.03M
Net Calls
+$869K
Net Calls Change
+$546K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$11.2M
2
Millennium Management
Millennium Management
New York
+$6.59M
3
AG
Algert Global
California
+$4.51M
4
Charles Schwab
Charles Schwab
California
+$4.19M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.87M

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$10.7M
2
WCM
Woodson Capital Management
Connecticut
-$7.21M
3
Invesco
Invesco
Georgia
-$4.37M
4
JF
Jump Financial
Illinois
-$3.44M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$3.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
PNC Financial Services Group
151
PNC Financial Services Group
Pennsylvania
$1.98K +$121 +12 +6%
US Bancorp
152
US Bancorp
Minnesota
$1.72K +$151 +15 +9%
SCM
153
Sterling Capital Management
North Carolina
$1.18K – – –
AAG
154
Armstrong Advisory Group
Massachusetts
$1.04K – – –
PFBT
155
Parkside Financial Bank & Trust
Missouri
$888 – – –
RA
156
Rise Advisors
New York
$494 +$535 +53 New
S
157
SignatureFD
Georgia
$411 – – –
LFG
158
Larson Financial Group
Missouri
$327 -$20 -2 -5%
RIL
159
Rothschild Investment LLC
Illinois
$280 -$858 -85 -74%
SS
160
Sunbelt Securities
Texas
$252 +$273 +27 New
FFA
161
Farther Finance Advisors
California
$140 +$151 +15 New
WCM
162
Woodson Capital Management
Connecticut
– -$7.21M -500,000 Closed
JF
163
Jump Financial
Illinois
– -$3.44M -238,600 Closed
Marshall Wace
164
Marshall Wace
United Kingdom
– -$2.34M -162,133 Closed
Tudor Investment Corp
165
Tudor Investment Corp
Connecticut
– -$2.3M -159,548 Closed
CCIA
166
Campbell & Co Investment Adviser
Maryland
– -$1.5M -104,431 Closed
SSA
167
Sierra Summit Advisors
Nevada
– -$1.3M -90,511 Closed
CSS
168
Cubist Systematic Strategies
Connecticut
– -$909K -63,105 Closed
FAM
169
Fred Alger Management
New York
– -$662K -45,923 Closed
JG
170
Jain Global
New York
– -$584K -40,500 Closed
IQI
171
Integrated Quantitative Investments
Washington
– -$373K -25,884 Closed
CIP
172
Cornerstone Investment Partners
Georgia
– -$353K -24,492 Closed
CIC
173
Chase Investment Counsel
Virginia
– -$349K -24,246 Closed
SPA
174
Sherbrooke Park Advisers
New York
– -$254K -17,656 Closed
VOYA Investment Management
175
VOYA Investment Management
Georgia
– -$207K -14,395 Closed
4 5 6
7
8

NAGE Hedge Fund Activity: Q3 2025 in Review

162 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q3 2025, worth a combined $296M — down 29% from $418M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NAGE positions and 24 closed out — a net gain of 8 holders — while 68 added to existing stakes and 38 trimmed.

The largest buyer was UBS Group, adding an estimated $11.2M. The largest seller was D.E. Shaw & Co, cutting an estimated $10.7M.

  • 162 institutional investors held Niagen Bioscience (NAGE) as of Q3 2025, up from 155 in Q2 2025.
  • Funds reported $296M of Niagen Bioscience stock for Q3 2025, down 29% quarter-over-quarter.
  • 32 funds opened new Niagen Bioscience positions in Q3 2025 and 24 closed out, a net change of +8 holders.
  • The largest Niagen Bioscience buyer in Q3 2025 was UBS Group, an estimated $11.2M added.
  • The largest Niagen Bioscience seller in Q3 2025 was D.E. Shaw & Co, an estimated $10.7M sold.

Based on aggregated 13F filings for Q3 2025.